Approximately 25% of women in the United States between ages 45 and 60 are at high risk for breast cancer and should consider ...

Tamoxifen is an oral anti-estrogen used to treat women with estrogen receptor positive breast cancer. It is taken once daily and blocks the estrogen receptor on cancer and normal cells. It ...

Tamoxifen (Nolvadex, Soltamox) is the most widely prescribed breast cancer therapy in the world. Some even call it the "backbone" of breast cancer treatment. Even with all that fanfare, tamoxifen ...

Women taking a new breast cancer drug are living longer than those taking Tamoxifen - the current 'gold standard' treatment. Doctors predict the new drug, Arimidex, will improve long-term survival ...

Background: Tamoxifen is standard adjuvant treatment for postmenopausal women with hormone-receptor-positive breast cancer. We assessed the benefit of adding chemotherapy to adjuvant tamoxifen and ...

Weekly administration of prophylactic tamoxifen is much less effective than the standard daily regimen in preventing the adverse breast effects induced by bicalutamide. Bicalutamide monotherapy is ...

Severe baseline hypercholesterolemia, hypertension, and BMI of ≥25 kg/m 2 were also revealed as independent predictors of the condition. In summary, the study showed that tamoxifen doubled the ...

Switching to an AI following 2–3 years of initial adjuvant tamoxifen is an effective option for patients unable to begin treatment with an AI. This article evaluates the most up-to-date results ...